NovaBay Pharmaceuticals, Inc. (NBY) EPS by Year
NovaBay Pharmaceuticals, Inc. does not report diluted earnings per share for fiscal year 2025, so the figure is not reported on this page. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters NovaBay Pharmaceuticals, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
NBY EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A | -$0.31 | -$0.48-4.3% | -$0.46+4.2% | -$0.48 | -$1.40 | -$6.82+10.8% | -$7.65+27.2% | -$10.51 | -$0.24-20.0% | -$0.20 |
NBY EPS (Diluted) by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What diluted earnings per share means
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.